One Risk Assessment Tool for Cardiovascular Disease, Type 2 Diabetes, and Chronic Kidney Disease
Open Access
- 13 March 2012
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 35 (4) , 741-748
Abstract
OBJECTIVE Individuals at high risk for chronic cardiometabolic disease (cardiovascular disease [CVD], type 2 diabetes, and chronic kidney disease [CKD]) share many risk factors and would benefit from early intervention. We developed a nonlaboratory-based risk-assessment tool for identification of people at high cardiometabolic disease risk. RESEARCH DESIGN AND METHODS Data of three population-based cohorts from different regions of the Netherlands were merged. Participants were 2,840 men and 3,940 women, white, aged 28–85 years, free from CVD, type 2 diabetes, and CKD diagnosis at baseline. The outcome was developing cardiometabolic disease during 7 years follow-up. RESULTS Age, BMI, waist circumference, antihypertensive treatment, smoking, family history of myocardial infarction or stroke, and family history of diabetes were significant predictors, whereas former smoking, history of gestational diabetes, and use of lipid-lowering medication were not. The models showed acceptable calibration (Hosmer and Lemeshow statistics, P > 0.05) and discrimination (area under the receiver operating characteristic [ROC] curve 0.82 [95% CI 0.81–0.83] for women and 0.80 [0.78–0.82] for men). Discrimination of individual outcomes was lowest for diabetes (area under the ROC curve 0.70 for men and 0.73 for women) and highest for CVD mortality (0.83 for men and 0.85 for women). CONCLUSIONS We demonstrate that a single risk stratification tool can identify people at high risk for future CVD, type 2 diabetes, and/or CKD. The present risk-assessment tool can be used for referring the highest risk individuals to health care for further (multivariable) risk assessment and may as such serve as an important part of prevention programs targeting chronic cardiometabolic disease.Keywords
This publication has 27 references indexed in Scilit:
- The Rotterdam Study: 2012 objectives and design updateEuropean Journal of Epidemiology, 2011
- N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general populationEuropean Heart Journal, 2009
- The Rotterdam Study: 2010 objectives and design updateEuropean Journal of Epidemiology, 2009
- Use of diagnostic self-tests on body materials among Internet users in the Netherlands: prevalence and correlates of useBMC Public Health, 2009
- A Simple Algorithm to Predict Incident Kidney DiseaseArchives of internal medicine (1960), 2008
- Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohortThe Lancet, 2008
- General Cardiovascular Risk Profile for Use in Primary CareCirculation, 2008
- The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general populationKidney International, 2005
- Validation and updating of predictive logistic regression models: a study on sample size and shrinkageStatistics in Medicine, 2004
- Framingham risk score and prediction of lifetime risk for coronary heart diseaseThe American Journal of Cardiology, 2004